VYOME HOLDINGS, INC. Increase (Decrease) in Other Current Liabilities
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Other Current Liabilities of -$248.12 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-12
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was -$125.34K, a 1320.37% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was -$122.78K.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $238.28K, a 910.43% increase year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was -$4.16K.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2025 was $200.55K, a 1552.39% increase from fiscal 2024.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2024 was $12.14K.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2020 was $2.27M.
- VYOME HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2019 was -$451.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 3 month as first filed | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 9 month as first filed | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$125.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$248.12K 10-Q · filed 2026-08-12 | -$9.84K derived: sum of 3 quarters · filed 2026-08-12 | -$14.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | -$122.78K 10-Q · filed 2026-05-12 | $115.50K derived: sum of 2 quarters · filed 2026-05-12 | $111.34K derived: sum of 3 quarters · filed 2026-05-12 | $121.61K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $238.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $234.12K derived: sum of 2 quarters · filed 2026-03-18 | $244.39K derived: sum of 3 quarters · filed 2026-08-12 | $200.55K 10-K · filed 2026-03-18 | |||
| 2025-09-30 | -$4.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.12K derived: sum of 2 quarters · filed 2026-08-12 | -$37.73K 10-Q · filed 2025-11-14 | -$14.15K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $10.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$33.57K 10-Q · filed 2026-08-12 | -$33.58K 8-K · filed 2025-09-02 | -$9.99K derived: sum of 3 quarters · filed 2026-08-12 | -$92.47K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$43.84K 10-Q · filed 2026-05-12 | -$20.26K derived: sum of 2 quarters · filed 2026-05-12 | -$102.74K derived: sum of 3 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $23.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$58.90K derived: sum of 2 quarters · filed 2026-03-18 | $12.14K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$82.48K derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14 | -$11.45K 10-Q · filed 2025-11-14 | |||||
| 2024-06-30 | $71.03K 8-K · filed 2025-09-02 | ||||||
| 2021-03-31 | $897.00K 10-Q · filed 2021-05-12 | $1.06M derived: sum of 2 quarters · filed 2021-05-12 | $1.09M derived: sum of 3 quarters · filed 2021-05-12 | $83.00K derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $189.00K derived: sum of 2 quarters · filed 2021-03-12 | -$814.00K derived: sum of 3 quarters · filed 2021-03-12 | $2.27M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$975.00K derived: sum of 2 quarters · filed 2020-11-06 | $2.11M 10-Q · filed 2020-11-06 | $2.02M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.08M 10-Q · filed 2020-07-30 | $1.99M derived: sum of 3 quarters · filed 2021-05-12 | $1.77M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-03-31 | $3.08M 10-Q · filed 2021-05-12 | $2.99M derived: sum of 2 quarters · filed 2021-05-12 | $2.77M derived: sum of 3 quarters · filed 2021-05-12 | $2.44M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$309.00K derived: sum of 2 quarters · filed 2021-03-12 | -$646.00K derived: sum of 3 quarters · filed 2021-03-12 | -$451.00K 10-K · filed 2021-03-12 | |||
| 2019-09-30 | -$221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$558.00K derived: sum of 2 quarters · filed 2020-11-06 | -$363.00K 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | -$337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$142.00K 10-Q · filed 2020-07-30 | |||||
| 2019-03-31 | $195.00K 10-Q · filed 2020-06-19 | ||||||
| 2018-09-30 | -$208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $727.00K derived: sum of 2 quarters · filed 2019-11-08 | $634.00K 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | $935.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $842.00K 10-Q · filed 2019-07-24 | $424.00K 10-Q · filed 2018-08-02 | ||||
| 2018-03-31 | -$93.00K 10-Q · filed 2019-05-10 | ||||||
| 2017-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $600.00K derived: sum of 2 quarters · filed 2018-11-02 | $506.00K 10-Q · filed 2018-11-02 | $467.00K 10-Q · filed 2017-11-03 | -$667.00K derived: sum of 4 quarters · filed 2018-11-02 | ||
| 2017-06-30 | $420.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $326.00K 10-Q · filed 2018-08-02 | -$847.00K derived: sum of 3 quarters · filed 2018-08-02 | $749.00K derived: sum of 4 quarters · filed 2018-08-02 | |||
| 2017-03-31 | -$94.00K 10-Q · filed 2018-05-10 | -$115.00K 10-Q · filed 2017-05-10 | -$1.27M derived: sum of 2 quarters · filed 2018-05-10 | $329.00K derived: sum of 3 quarters · filed 2018-05-10 | $425.00K derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $423.00K derived: sum of 2 quarters · filed 2017-11-03 | $519.00K derived: sum of 3 quarters · filed 2017-11-03 | $517.00K 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $1.69M derived: sum of 2 quarters · filed 2017-11-03 | $1.69M 10-Q · filed 2017-11-03 | $1.60M derived: sum of 4 quarters · filed 2017-11-03 | |||
| 2016-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $94.00K 10-Q · filed 2017-08-02 | $3.00K derived: sum of 3 quarters · filed 2017-08-02 | ||||
| 2016-03-31 | -$2.00K 10-Q · filed 2017-05-10 | -$93.00K derived: sum of 2 quarters · filed 2017-05-10 | |||||
| 2015-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $111.00K 10-K · filed 2017-02-23 | |||||
| 2015-09-30 | $202.00K 10-Q · filed 2016-11-10 | ||||||
| 2014-12-31 | $6.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |